Karine Lacombe
Karine Lacombe has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
P.-M. Girard
10 shared publicationsA. Boyd
8 shared publicationsJ. Bottero
6 shared publicationsJ. Gozlan
6 shared publicationsA. Collignon
4 shared publicationsB. Varsat
4 shared publications
Latest Publications
- 1 January 2017
- Published by Elsevier in Journal of Hepatology
- Vol. 66 (1) , S424-S425
Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients
- 1 January 2017
- Published by Elsevier in Journal of Hepatology
- Vol. 66 (1) , S424-S425
Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients
- 1 January 2016
- Published by Elsevier in Journal of Hepatology
- Vol. 64 (2) , S162-S163
Decay of Ccc-Dna is Slow and Marks Persistence of Intrahepatic Viral Dna Synthesis during Long-Term Tenofovir Treatment in Hiv-Hbv Co-Infected Patients
- 1 January 2016
- Published by Elsevier in Journal of Hepatology
- Vol. 64 (2) , S162-S163
Decay of Ccc-Dna is Slow and Marks Persistence of Intrahepatic Viral Dna Synthesis during Long-Term Tenofovir Treatment in Hiv-Hbv Co-Infected Patients
- 1 April 2015
- Published by Elsevier in Journal of Hepatology
- Vol. 62, S827
P1253 : Simultaneous HIV-HBV-HCV point-of-care tests improve the screening outcomes
- 1 April 2015
- Published by Elsevier in Journal of Hepatology
- Vol. 62, S827
P1253 : Simultaneous HIV-HBV-HCV point-of-care tests improve the screening outcomes
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S520
P1291 EFFECTIVENESS OF HBV RAPID TESTS IN INVOLVEMENT OF CARE. RESULTS OF A RANDOMIZED, MULTICENTER STUDY
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S520
P1291 EFFECTIVENESS OF HBV RAPID TESTS IN INVOLVEMENT OF CARE. RESULTS OF A RANDOMIZED, MULTICENTER STUDY
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S437-S438
P1081 VACCINE ESCAPE MUTANTS AND SUBOPTIMAL HEPATITIS B VIRUS RESPONSE IN HIV–HBV COINFECTED PATIENTS FROM SUB-SAHARAN AFRICA
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S437-S438
P1081 VACCINE ESCAPE MUTANTS AND SUBOPTIMAL HEPATITIS B VIRUS RESPONSE IN HIV–HBV COINFECTED PATIENTS FROM SUB-SAHARAN AFRICA
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S489
P1203 EFFICACY AND SAFETY OF TELAPREVIR-BASED TRIPLE THERAPY IN HIV/HCV COINFECTED VERSUS HCV MONOINFECTED PATIENTS: A MATCHED-COHORT STUDY
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S489
P1203 EFFICACY AND SAFETY OF TELAPREVIR-BASED TRIPLE THERAPY IN HIV/HCV COINFECTED VERSUS HCV MONOINFECTED PATIENTS: A MATCHED-COHORT STUDY
- 1 April 2013
- Published by Elsevier in Journal of Hepatology
- Vol. 58, S21
47 TESTING FOR HEPATITIS B VIRUS (HBV) ALONE DOES NOT INCREASE VACCINE COVERAGE IN NON-IMMUNIZED PERSONS
- 1 April 2013
- Published by Elsevier in Journal of Hepatology
- Vol. 58, S21
47 TESTING FOR HEPATITIS B VIRUS (HBV) ALONE DOES NOT INCREASE VACCINE COVERAGE IN NON-IMMUNIZED PERSONS
- 30 April 2012
- Published by Elsevier in Journal of Hepatology
- Vol. 56, S11
24 MISSED OPPORTUNITIES FOR HBV SCREENING: RESULTS OF A LARGE SCREENING CAMPAIGN IN THE COMMUNITY, FRANCE 2011
- 30 April 2012
- Published by Elsevier in Journal of Hepatology
- Vol. 56, S11
24 MISSED OPPORTUNITIES FOR HBV SCREENING: RESULTS OF A LARGE SCREENING CAMPAIGN IN THE COMMUNITY, FRANCE 2011
- Open Access
- 1 December 2008
- Published by SAGE Publications in Journal of the International Association of Physicians in AIDS Care
- Vol. 7 (6) , 311-316
Sustained Increase of HDL Cholesterol Over a 72-Week Period in HIV-Infected Patients Exposed to an Antiretroviral Regimen Including Lopinavir/Ritonavir
Metabolic disorders are a major concern during antiretroviral therapy, especially for their potential to increase cardiovascular disease risk. In a multicenter, prospective study conducted in patients exposed to an antiretroviral regimen including lopinavir boosted with ritonavir, an early and sustained increase of high-density lipoprotein cholesterol was observed over a 72-week period. This increase was positively correlated with the exposure to lopinavir/ritonavir during the first 24 weeks.
- 1 December 2008
- Published by SAGE Publications in Journal of the International Association of Physicians in AIDS Care
- Vol. 7 (6) , 311-316
Open AccessSustained Increase of HDL Cholesterol Over a 72-Week Period in HIV-Infected Patients Exposed to an Antiretroviral Regimen Including Lopinavir/Ritonavir
Metabolic disorders are a major concern during antiretroviral therapy, especially for their potential to increase cardiovascular disease risk. In a multicenter, prospective study conducted in patients exposed to an antiretroviral regimen including lopinavir boosted with ritonavir, an early and sustained increase of high-density lipoprotein cholesterol was observed over a 72-week period. This increase was positively correlated with the exposure to lopinavir/ritonavir during the first 24 weeks.